Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Research on Parkinson's disease immunotherapy: a bibliometric analysis via multiple databases
Xinxing Fei1, Shiqi Wang2,3, Jiayi Song4,5
1Department of Psychiatry, Chengdu Eighth People's Hospital (Geriatric Hospital of Chengdu Medical College), Chengdu, China.
This bibliometric analysis maps the research landscape of Parkinson's disease (PD) immunotherapy, revealing key trends and collaborations. Future research should focus on clinical trials for precise immunological interventions in PD.
Area of Science:
- Neuroscience
- Immunology
- Bibliometrics
Background:
- Parkinson's disease (PD) is characterized by neurodegeneration, alpha-synuclein aggregation, and neuroinflammation.
- Despite rapid advancements in PD immunotherapy research, a comprehensive bibliometric analysis is lacking.
Purpose of the Study:
- To conduct a bibliometric analysis of Parkinson's disease immunotherapy research.
- To identify research trends, key contributors, and emerging themes in PD immunotherapy.
Main Methods:
- Literature search in Web of Science Core Collection and Scopus.
- Bibliometric analysis using Bibliometrix software.
- Summarization of clinical trial characteristics from PubMed and trial registries.
Main Results:
- Analysis of 890 documents from 488 sources, involving 3,804 researchers across 1,483 institutions and 63 countries.
- Identification of "Parkinson's disease", "immunotherapy", and "alpha-synuclein" as frequent keywords.
- Mapping revealed two main research clusters and inclusion of 8 clinical trials focused on active immunotherapy and targeted antibodies.
Conclusions:
- The field of PD immunotherapy shows significant development potential.
- Current research emphasizes understanding pathological mechanisms and developing novel therapeutic strategies.
- Future directions include precise immunological interventions and large-scale randomized controlled trials for enhanced clinical translation.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
